3.77MMarket Cap-101P/E (TTM)
0.6800High0.6001Low18.91KVolume0.6400Open0.6591Pre Close12.28KTurnover0.36%Turnover RatioLossP/E (Static)5.80MShares4.470052wk High2.02P/B3.43MFloat Cap0.552552wk Low--Dividend TTM5.28MShs Float8792.0000Historical High--Div YieldTTM12.12%Amplitude0.5525Historical Low0.6490Avg Price1Lot Size
Hepion Pharmaceuticals Stock Forum
Pharma Two B and Hepion Pharmaceuticals, Inc. Announce Filing of Registration Statement on Form F-4 Related to Proposed Merger
Hepion Pharmaceuticals (NASDAQ:HEPA) said it has begun winding down its ASCEND-NASH Phase 2 study for its drug rencofilstat as it continues to explore strategic alternatives for the company.
“We are disappointed to announce the wind-down of our Phase 2 NASHtr...
No comment yet